1887

Abstract

To evaluate the genetic variability of human parvovirus B19, the complete coding region of the VP1/VP2 structural proteins of 29 B19 isolates obtained from 25 infected patients were sequenced and compared with each other and with two previously published B19 isolates. The VP1/VP2 gene was amplified by PCR using B19-specific oligonucleotide primers and the amplification products were sequenced directly. Overall, the average nucleotide and predicted amino acid identity among B19 isolates was high. Sequential virus isolates from the same cases and isolates obtained from two cases linked by transmission in the same household were essentially identical. Sequence variation was minimal among isolates obtained from a single community-wide B19 outbreak, ranging between 0 and 10 (0.4%) base substitutions, although there appeared to be more than one genetic lineage circulating in the outbreak. A comparison with 18 additional isolates from distinct epidemiological settings found greater variability. These isolates differed from each other by between 11 (0.5%) and 112 (4.8%) base substitutions. B19 isolates from Xi'an, China, were significantly different from other isolates at both the nucleotide and amino acid levels, and were more closely related to a single isolate from Japan, obtained 10 years earlier, than to isolates from other countries. Isolates examined in this study included distinct genotypes from patients with similar clinical presentations and similar genotypes from patients with diverse clinical presentations. These data suggest that geographically defined genetic lineages of B19 may exist and that no particular B19 genotype was associated with a particular clinical outcome.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-11-2767
1996-11-01
2023-02-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/11/JV0770112767.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-11-2767&mimeType=html&fmt=ahah

References

  1. Blundell M. C., Beard C., Astell C. R. 1987; In vitro identification of a B19 parvovirus promoter. Virology 157:534–538
    [Google Scholar]
  2. Brown C. S., Jensen T., Meloen R. H., Puijk W., Sugamura K., Sato H., Spaan W. J. M. 1992; Localization of an immunodominant domain on baculovirus produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle. Journal of Virology 66:6989–6996
    [Google Scholar]
  3. Brown K. E., Young N. S., Liu J. M. 1994; Molecular, cellular and clinical aspects of parvovirus B19 infection. Critical Reviews in Oncology/ Hematology 16:1–31
    [Google Scholar]
  4. Chorba T., Coccia P., Holman R. C., Tattersall P., Anderson L. J., Sudman J., Young N. S., Kurczynski E., Saarinen U. M., Moir R., Lawrence D. N., Jason J. M., Evatt B. 1986; The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). Journal of Infectious Diseases 154:383–393
    [Google Scholar]
  5. Devereux J., Haeberli P., Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
    [Google Scholar]
  6. Durigon E. L., Erdman D. D., Gary G. W., Pallansch M. A., Török T. J., Anderson L. J. 1993; Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. Journal of Virological Methods 44:155–165
    [Google Scholar]
  7. Erdman D. D., Usher J., Tsou C., Caul E. O., Gary G. W., Kajigaya S., Young N. S., Anderson L. J. 1991; Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. Journal of Medical Virology 35:110–115
    [Google Scholar]
  8. Gallinella G., Venturoli S., Gentilomi G., Musiani M., Zerbini M. 1995; Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus. Archives of Virology 140:1119–1125
    [Google Scholar]
  9. Finkel T. H., Török T. J., Ferguson P. J., Durigon D. L., Zaki S. R., Leung D. Y. M., Harbeck R. J., Gelfand E. W., Saulsbury F. T., Hollister J. R., Anderson L. J. 1994; Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?. Lancet 343:1255–1258
    [Google Scholar]
  10. Kerr J. R., Curran M. D., Moore J. E., Erdman D. D., Coyle P. V., Nunoue T., Middleton D., Ferguson W. P. 1995; Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing. Journal of Virological Methods 53:213–222
    [Google Scholar]
  11. Mori J., Beattie P., Melton D. W., Cohen B. J., Clewley J. P. 1987; Structure and mapping of the DNA of human parvovirus B19. Journal of General Virology 68:2797–2806
    [Google Scholar]
  12. Morinet F., Trantschin J. D., Perol Y., Siegl G. 1986; Comparison of 17 isolates of the parvovirus B19 by restriction enzyme analysis. Archives in Virology 90:165–172
    [Google Scholar]
  13. Murphy F. A., Fauquet C. M., Bishop D. H. L., Ghabrial S. A., Jarvis A. W., Martelli G. P., Mayo M. A., Summers M. D. (editors) 1995 Virus Taxonomy: Classification and Nomenclature of Viruses. Sixth Report of the International Committee on Taxonomy of Viruses Wien & New York: Springer-Verlag;
    [Google Scholar]
  14. Rosenfeld S. J., Yoshimoto K., Kajigaya S., Anderson S., Young N. S., Field A., Warrener P., Bansal G., Collett M. S. 1992; Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. Journal of Clinical Investigation 89:2023–2029
    [Google Scholar]
  15. Saikawa T., Anderson S., Momoeda M., Kajigaya S., Young N. S. 1993; Neutralizing linear epitopes on B19 parvovirus cluster in the VP1 unique and VP1–VP2 junction regions. Journal of Virology 67:3004–3009
    [Google Scholar]
  16. Sato H., Hirata J., Kuroda N., Shiraki H., Maeda Y., Okochi K. 1991; Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies. Journal of Virology 65:5485–5490
    [Google Scholar]
  17. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58:921–936
    [Google Scholar]
  18. Török T. J. 1992; Parvovirus B19 and human disease. Advances in Internal Medicine 37:431–455
    [Google Scholar]
  19. Tsao J., Chapman M. S., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T. J., Rossmann M. G., Compans R. W. 1991; The three-dimensional structure of canine parvovirus and its functional implications. Science 251:1456–1464
    [Google Scholar]
  20. Umene K., Nunoue T. 1990; The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence. Journal of General Virology 71:983–986
    [Google Scholar]
  21. Umene K., Nunoue T. 1991; Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or five base pairs and partial nucleotide sequencing: use of sequence variability in virus classification. Journal of General Virology 72:1997–2001
    [Google Scholar]
  22. Umene K., Nunoue T. 1993; Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia. Journal of Medical Virology 39:333–339
    [Google Scholar]
  23. Umene K., Nunoue T. 1995; A new genome type of human parvovirus B19 present in sera of patients with encephalopathy. Journal of General Virology 76:2645–2651
    [Google Scholar]
  24. Yoshimoto K., Rosenfeld S., Frickhofen N., Kennedy D., Hills R., Kajigaya S., Young N. S. 1991; A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. Journal of Virology 65:7056–7060
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-11-2767
Loading
/content/journal/jgv/10.1099/0022-1317-77-11-2767
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error